Chlorthalidone
Rank #406 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$21.8M
Total Cost
966,780
Total Claims
$21.8M
Total Cost
34,032
Prescribers
$23
Cost per Claim
149,872
Beneficiaries
2,316,020
30-Day Fills
$641
Avg Cost/Provider
28
Avg Claims/Provider
Share of Medicare Part D Spending
0.01%
of total Medicare Part D spending
$21.8M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $21.8M total
Top Prescribers of Chlorthalidone
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Hanumandla Reddy | Cardiology | Hanford, CA | 538 | $19K |
| 2 | Humberto Machado | Cardiology | Coral Gables, FL | 663 | $18K |
| 3 | Andrew Miller | Cardiology | Birmingham, AL | 634 | $16K |
| 4 | Victor Lopez-Llavona | Internal Medicine | Vega Baja, PR | 271 | $13K |
| 5 | Jose Bautista | Internal Medicine | Sanger, CA | 344 | $13K |
| 6 | Anthony Fletcher | Interventional Cardiology | Little Rock, AR | 617 | $11K |
| 7 | David Evans | Cardiology | Searcy, AR | 458 | $11K |
| 8 | Cres Miranda | Cardiology | Las Vegas, NV | 494 | $11K |
| 9 | Larry Shea Hailey | Emergency Medicine | Meridian, MS | 560 | $11K |
| 10 | Eric Aviles | Cardiology | Cayey, PR | 515 | $11K |
| 11 | Luis Rodriguez Hernandez | Internal Medicine | Ponce, PR | 277 | $10K |
| 12 | Kevin O'reilly | Nephrology | Grove City, OH | 310 | $9,826 |
| 13 | Nicholas Mayer | Internal Medicine | Florissant, MO | 442 | $9,602 |
| 14 | Alejandro Lopez-Mas | Cardiology | Ponce, PR | 312 | $8,969 |
| 15 | Miguel Rodriguez Burgos | Cardiology | Juncos, PR | 508 | $8,914 |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 403 | Loteprednol Etabonate (Loteprednol Etabonate) | $22.1M | 85,761 |
| 404 | Mycophenolate Mofetil (Mycophenolate Mofetil) | $22.0M | 152,937 |
| 405 | Tolterodine Tartrate (Tolterodine Tartrate Er) | $21.8M | 178,340 |
| 406 | Chlorthalidone (Chlorthalidone) | $21.8M | 966,780 |
| 407 | Ondansetron (Ondansetron Odt) | $21.5M | 1,261,950 |
| 408 | Asciminib Hydrochloride (Scemblix) | $21.4M | 830 |
| 409 | Cephalexin (Cephalexin) | $21.4M | 2,407,718 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology